Tests a fracture liaison service and osteoporosis medication monitoring in rural Taiwan
Follows adults over 50 with osteoporosis or fractures, with education, follow-up and medication monitoring.
Key facts
- Who runs it
- National Taiwan University Hospital
- Where
- Hsinchu, TaiwanSee the site
- Trial code
- Registry title
- Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- Sept 2015
- Expected to end
- Dec 2026
- Type of study
- Observational, 2 groups
- Record updated
- 23 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for people aged 50 or older with a new hip or spine fracture, or who take or are starting osteoporosis medicine.
- Age
- 50 years or older
- Sex
- All sexes can join
- Disease stage
- A new hip fracture, a newly found spine (vertebral) fracture, or osteoporosis medicine that is new, changed or not taken as prescribed.
- Earlier treatment
- People with a recent change of osteoporosis medicine, or poor adherence to it, can join. Newly prescribed osteoporosis medicine also counts.
Main reasons for not taking part
- Life expectancy less than 2 years, or cannot be assessed because of communication problems
- Atypical fractures
- Taking part in other medication clinical trials
- Unwilling to accept the assessment and treatment
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age >=50 and one of the below
- New hip fracture in orthopedic ward
- Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics
- Newly prescribed with AOMs
- Recent change of AOMs
- Poor adherence to AOMs
- Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements
Who cannot take part
- Patient in other medication clinical trials
- Life expectancy less than 2 years or can't be assessed for communication problems
- Atypical fractures
- Unwilling to accept the assessment and treatment
Where in Taiwan
- National Taiwan University Hospital, Chutung branchHsinchu, TaiwanContact: Ding-Cheng Chan, MD,PHDTaking people
About the trial
What the trial wants to find out
Aims: (1) to Establish the FLS services at the National Taiwan University Hospital Jinshan Branch. (2) To establish a anti-osteoporosis medication management service at Jinshan Branch.
Read full original descriptionShow less
Method: From Aug., 2015, a fracture liaison services (FLSs) following the 13 'Capture the Fracture Best Practice Standards' were implemented at the National Taiwan University Hospital Jinshan Branch health care system. The Jinshan Branch program enrolled patient with 1) new hip fracture 2) newly identified vertebral fractures (radiological or clinical) from both inpatients and outpatients. At the same time, a osteoporosis medication management service is also establish as a complement of FLS to enroll patients on antiosteoporosis medications (AOMs) but not necessary with fracture.
Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases.
During the whole study period, the investigators planed to enroll 200 patients (with or without fracture). Each patient would be assessed at baseline, and every 4 months last for two years.
The 2 groups in the trial
- FLS
Patients with new hip fracture or newly identified vertebral fractures
- MMS
Patients prescribed with anti-osteoporosis medications but not fit FLS requirements
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study in Rural Area
- Plain-language title
- Tests a fracture liaison service and osteoporosis medication monitoring in rural TaiwanGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 23 December 2025